Extensive-Stage Small Cell Lung Cancer
Extensive-stage small cell lung cancer (ES-SCLC) is an aggressive type of lung cancer that has spread beyond the lungs to other parts of the body, making it more challenging to treat.
Advanced Small Cell Lung Cancer: BI 764532 Study
We are testing how well different doses of a new medication work with standard care for people with advanced small cell lung cancer. This study aims to see how well patients tolerate the treatment.
What diseases are being studied?
Health conditions and diseases that the clinical trial is designed to study and treat.
Where is the clinical trial being conducted?
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Loading map...
Algemeen Ziekenhuis Groeninge
Longziekten
Kortrijk, Belgium
Cliniques Universitaires Saint-Luc
Medical Oncology
Sint-Stevens-Woluwe, Belgium
Institut Bergonie
Early Phase Trials and Sarcoma Units
Bordeaux, France
Sponsor: Boehringer Ingelheim International GmbH
Last updated: Nov 27, 2025
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.